News for Athenex, Inc. (2MT.F)

LOS ANGELES, March 5, 2021 /PRNewswire/ --   The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Athenex, Inc. securities between August... | March 5, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...

CALGARY, AB, March 5, 2021 /CNW/ - Avanti Software, a leader in Canadian People Management solutions has made it to the 2021 list of Top 50 Great Places to Work® in CanadaSince 2018, Avanti Software has been consistently designated Great Place to Work® Certified and has been listed as a top Alberta employer, as well as a Best Workplace for Millennials and Youth, and Technology. This is the organization's first time on Top 50 Great Places to Work® in Canada list.

Glancy Prongay & Murray LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Athenex, Inc. investors concerning the... | March 4, 2021

Hagens Berman urges XL Fleet Corp. (NYSE: XL) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States

SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Athenex, Inc. (NASDAQ:ATNX) investors with significant losses to submit your losses ...

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Athenex, Inc. (NASDAQ: ATNX). Such investors are advised to contact Robert S....

/PRNewswire/ -- Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. The firm is investigating...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ma...

Today's Daily Dose brings you news about the regulatory set back of Athenex's oral Paclitaxel and CorMedix's Defencath, ASLAN Pharma's Atopic Dermatitis trial results, FDA panel review of FibroGen's Roxadustat, Morphic Therapeutic's Phase 1 single ascending dose clinical trial of MORF-057, which is in development for the treatment of inflammatory bowel disease, and STRATA Skin's CEO transition.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.95%

Midway through trading Monday, the Dow traded up 2.09% to 31,580.33 while the NASDAQ rose 2.56% to 13,530.07. The S&P also rose, gaining 2.28% to ...